Identification of Ultibro Breezhaler:
No description |
Search images on Google Product Monograph
Active Ingredients:
- glycopyrronium (glycopyrronium bromide), 50 MCG
- indacaterol (indacaterol maleate), 110 MCG
DIN: 02418282
Dosage Form(s): CAPSULE
Route(s) of Administration: INHALATION
Description: CAPSULE TO BE USED ONLY WITH ULTIBRO BREEZHALER DEVICE - ORAL INHALATION
Schedule: Prescription
Company: NOVARTIS PHARMACEUTICALS CANADA INC – official site
ATC:
- R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, WHO, Wiki)
- R03A - ADRENERGICS, INHALANTS (ATC, WHO)
- R03AL - Adrenergics in combination with anticholinergics (ATC, WHO)
- R03AL04 - INDACATEROL AND GLYCOPYRRONIUM BROMIDE (WHO)
Reference brand drug: Ultibro
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 30
External Links for Ultibro Breezhaler:
Search on Google
- Ultibro Breezhaler side effects
- Ultibro Breezhaler dosage
- glycopyrronium side effects
- glycopyrronium dosage
- indacaterol side effects
- indacaterol dosage
Novartis Pharmaceuticals Canada Inc
Go to Novartis website to see drug product details. Sometimes you can find ultibro breezhaler photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.